Changeflow GovPing Healthcare & Life Sciences Single Cell Library Construction with Tissue Lo...
Routine Notice Added Final

Single Cell Library Construction with Tissue Location Data

Favicon for changeflow.com USPTO Patent Applications - Biotech (C12N)
Published
Detected
Email

Summary

Beijing SeekGene Biosciences Co., Ltd. filed US Patent Application US20260109969A1 for a method of constructing a single cell library containing tissue location information and an associated sequencing method, published April 23, 2026. The application names eight inventors and describes a five-step process enabling simultaneous analysis of spatial location and genetic information at the single cell level. Patent prosecution would determine whether claims covering the chip-based binding, tissue dissociation, and high-throughput library construction method are allowed.

“According to the method, spatial location information of a single cell can be tested while analyzing genetic information on a single cell level.”

USPTO , verbatim from source
Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Applications - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 264 changes logged to date.

What changed

Beijing SeekGene Biosciences Co., Ltd. seeks patent protection for a method that constructs single cell libraries retaining tissue spatial location information, enabling simultaneous transcriptome and spatial genomic analysis. The five-step method involves providing a chip with location-encoded nucleic acid molecules, binding tissue slices to the chip, dissociating bound tissue into single cell suspension, and constructing both transcriptome and spatial barcoded libraries for sequencing.

Biotechnology and life sciences companies engaged in single cell genomics, spatial transcriptomics, or drug discovery research should monitor this application's prosecution to assess potential freedom-to-operate considerations. Competitors developing similar spatial profiling technologies may need to evaluate whether the disclosed methods and chip configurations could overlap with their own research programs or existing patent portfolios.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

METHOD FOR CONSTRUCTING SINGLE CELL LIBRARY CONTAINING TISSUE LOCATION INFORMATION AND SEQUENCING METHOD

Application US20260109969A1 Kind: A1 Apr 23, 2026

Assignee

BEIJING SEEKGENE BIOSCIENCES CO., LTD.

Inventors

Jinhuan Han, Ying Guan, Xiaoling Zhi, Min Zhi, Guoqin Sang, Huanhuan Shi, Shaozhuo Jiao, Zongwen Li

Abstract

Disclosed in the present invention are a method for constructing a single cell library containing tissue location information and a sequencing method. The construction method comprises the following steps: S10, providing a chip, wherein the chip is provided with a plurality of sites, each site is provided with nucleic acid molecules having a known base sequence, and the nucleic acid molecules contain location information; S20, enabling a tissue slice to be tested to be in contact with the chip, so as to bind the nucleic acid molecules having the known base sequence in the chip to cells of said tissue slice to obtain a bound tissue slice; S30, dissociating the bound tissue slice to prepare a single cell suspension; S40, constructing a library for the single cell suspension by means of a high-throughput single cell library construction and sequencing platform, to obtain a transcriptome library and a spatial barcoded library; and S50, sequencing the transcriptome library and the spatial barcoded library to obtain a single cell library containing tissue location information. According to the method, spatial location information of a single cell can be tested while analyzing genetic information on a single cell level.

CPC Classifications

C12N 15/1065

Filing Date

2024-02-07

Application No.

19117937

View original document →

Get daily alerts for USPTO Patent Applications - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 23rd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260109969A1

Who this affects

Applies to
Pharmaceutical companies Manufacturers
Industry sector
3254.1 Biotechnology
Activity scope
Patent application filing Research and development
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Biotechnology Pharmaceuticals

Get alerts for this source

We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!